Q32 Bio (QTTB)
NASDAQ:QTTB
Holding QTTB?
Track your performance easily

Q32 Bio (QTTB) Financial Statements

751 Followers

Q32 Bio Financial Overview

Q32 Bio's market cap is currently ―. The company's EPS TTM is $-23.001; its P/E ratio is -2.20; Q32 Bio is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue----$ 354.00K
Gross Profit----$ 354.00K
EBIT$ -16.98M$ -14.86M$ -2.15M$ -29.58M$ -29.30M
EBITDA$ -16.65M$ -14.57M$ -2.82M$ -30.20M$ -29.70M
Net Income Common Stockholders$ -16.98M$ 1.00M$ -29.40M$ -19.67M$ -35.04M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 107.65M$ 135.31M$ 82.65M$ 103.30M$ 127.07M
Total Assets$ 124.21M$ 152.33M$ 84.56M$ 140.06M$ 169.32M
Total Debt$ 18.50M$ 18.59M$ 1.32M$ 28.34M$ 28.72M
Net Debt$ -89.14M$ -116.72M$ -81.33M$ -74.96M$ -98.35M
Total Liabilities$ 90.70M$ 103.56M$ 11.57M$ 51.85M$ 49.96M
Stockholders Equity$ 33.51M$ 48.77M$ 72.99M$ 88.21M$ 119.40M
Cash Flow-
Free Cash Flow$ -22.23M$ -14.55M$ -21.36M$ -24.60M$ -23.66M
Operating Cash Flow$ -22.21M$ -14.55M$ -21.57M$ -24.94M$ -23.66M
Investing Cash Flow$ 9.89M$ 97.00K$ 31.72M$ -22.76M$ 61.00M
Financing Cash Flow$ -5.52M$ 99.35M$ 14.00K$ 18.00K$ 2.00K
Currency in USD

Q32 Bio Earnings and Revenue History

Q32 Bio Debt to Assets

Q32 Bio Cash Flow

Q32 Bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis